FDA Makes Broad Concessions In Settling Pacira Promotion Suit

Agency will formally rescind Exparel warning letter and expand labeling to clarify that pain drug is not limited to any specific surgery.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from United States

More from North America